Stock Events

Stock Events

Orexo AB 

$2.8
2
+$0+0% Thursday 13:30

Statistics

Day High
2.8
Day Low
2.8
52W High
4.05
52W Low
1.48
Volume
1
Avg. Volume
1
Mkt Cap
97.17M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

28AprExpected
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Next
-0.3
-0.21
-0.12
-0.03
Expected EPS
N/A
Actual EPS
N/A

Financials

-34.29%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
107.07MRevenue
-36.71MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ORXOY. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alkermes
ALKS
Mkt Cap5.07B
Alkermes plc develops treatments for disorders like addiction and depression, overlapping with Orexo's product range.
Collegium Pharmaceutical
COLL
Mkt Cap1.13B
Collegium Pharmaceutical, Inc. provides pain management solutions that compete with Orexo’s interests in opioid addiction treatments.
Supernus Pharmaceuticals
SUPN
Mkt Cap3.12B
Supernus Pharmaceuticals, Inc. focuses on central nervous system diseases, a field relevant to Orexo's psychiatric and neurological product lines.
Amphastar Pharmaceuticals
AMPH
Mkt Cap1.19B
Amphastar Pharmaceuticals manufactures drugs, including naloxone, used in opioid overdose, relevant to Orexo’s addiction treatment market.
Acura Pharmaceuticals
ACUR
Mkt Cap1.05M
Acura Pharmaceuticals, Inc. is involved in developing technologies to deter drug abuse, competing in the opioid management space.
Pacira BioSciences
PCRX
Mkt Cap997.06M
Pacira BioSciences, Inc. offers non-opioid pain management solutions, which is a growing alternative to traditional opioid treatments, impacting Orexo's market indirectly.

About

Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Its products include Zubsolv tablets for the treatment of opioid dependence; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of short-term insomnia. The company's development products comprise OX124, a medication for naloxone rescue; OX125, a medication for nalmefene rescue; OX640, a medication for allergic reactions; and OX338 sublingual tablet formulation of ketorolac for treatment of moderate to severe pain. It is also developing OX-MPI program for the treatment of microvascular diseases in chronic inflammatory conditions. The company's digital therapies comprise deprexis therapy for the treatment of mild to severe depression; vorvida for alcohol use disorder; and modia for opioid use disorder. Orexo AB (publ) was incorporated in 1994 and is headquartered in Uppsala, Sweden.
Show more...
CEO
Mr. Nikolaj Sorensen
Employees
110
Country
US
ISIN
US68616W1027

Listings

LSE
GB
0H19.LSE
OTC Link
US
ORXOY
ST
SE
ORX.ST
F
DE
C5G.F

0 Comments

Share your thoughts

FAQ

What is Orexo AB stock price today?▼
The current price of ORXOY is $2.8 USD — it has increased by +0% in the past 24 hours. Watch Orexo AB stock price performance more closely on the chart.
What is Orexo AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Orexo AB stocks are traded under the ticker ORXOY.
What is Orexo AB market cap?▼
Today Orexo AB has the market capitalization of 97.17M
When is the next Orexo AB earnings date?▼
Orexo AB is going to release the next earnings report on April 28, 2026.
What is Orexo AB revenue for the last year?▼
Orexo AB revenue for the last year amounts to 107.07M USD.
What is Orexo AB net income for the last year?▼
ORXOY net income for the last year is -36.71M USD.
How many employees does Orexo AB have?▼
As of April 01, 2026, the company has 110 employees.
In which sector is Orexo AB located?▼
Orexo AB operates in the Health Care sector.
When did Orexo AB complete a stock split?▼
Orexo AB has not had any recent stock splits.
Where is Orexo AB headquartered?▼
Orexo AB is headquartered in Uppsala, US.